Insider trades
Utter Christine Marie, CAO of PTC Therapeutics PTCT, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $1.9M. The latest trade was on 06/17.
Utter Christine Marie
SVP, Chief Accounting Officer
- Company
- PTC Therapeutics PTCT
- First filing
- 23/01/09
- Trades
- 56 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$1.9M
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 06/17 | 06/22 | 19,686 sh | $75.56 | $1,487,474.16 | −21.9% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 02/18 | 02/20 | 2,494 sh | $69.36 | $172,983.84 | −3.4% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 01/08 | 01/12 | 1,034 sh | $76.45 | $79,049.3 | −1.4% |
PTCT | Open-market sale10b5-1 plan | 01/06–01/07 | 01/08 | 2,616 sh2 trades | $77.19avg. | $201,918.7 | −3.4% |
PTCT | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 1,757 sh2 trades | $50.11avg. | $88,043.26 | −2.7% |
PTCT | Open-market sale10b5-1 plan | 25/01/07–25/01/08 | 25/01/10 | 2,953 sh2 trades | $44.87avg. | $132,492.94 | −4.4% |
PTCT | Open-market sale10b5-1 plan | 24/12/02 | 24/12/04 | 17,800 sh4 trades | $51.77avg. | $921,585.17 | −25.3% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/01/30 | 24/02/01 | 318 sh | $27.25 | $8,665.5 | −0.9% |
PTCT | Open-market sale10b5-1 plan | 24/01/08–24/01/09 | 24/01/10 | 2,841 sh2 trades | $28.86avg. | $81,977.85 | −7.3% |
PTCT | Open-market sale10b5-1 plan | 23/04/21 | 23/04/25 | 4,692 sh3 trades | $55.06avg. | $258,320.44 | −11.0% |
PTCT | Open-market sale10b5-1 plan | 23/03/29 | 23/03/31 | 4,688 sh2 trades | $47.79avg. | $224,057.58 | −11.0% |
PTCT | Open-market sale10b5-1 plan | 23/03/27 | 23/03/29 | 26,658 sh6 trades | $45.10avg. | $1,202,161.65 | −41.2% |
PTC TherapeuticsPTCT | Open-market sale | 23/01/31 | 23/02/02 | 325 sh | $45.63 | $14,829.75 | −0.8% |
PTCT | Open-market sale | 23/01/10–23/01/11 | 23/01/12 | 906 sh2 trades | $43.59avg. | $39,490.89 | −2.3% |
PTC TherapeuticsPTCT | Open-market sale | 23/01/09 | 23/01/11 | 706 sh | $41.66 | $29,411.96 | −1.8% |